Anti-tumor effects were observed with Lactobacillus bulgaricus; its administration in an AOM/DSS-induced CAC mouse model suppressed mean tumor size and total tumor volume, significantly reducing pro-inflammatory cytokines, including IL-6, TNF-α, IL-1β, IL-17, and IL-23 (179). The gene discussed is IL17A; the disease is neoplasm.